Becton Dickinson prepares to say goodbye to its $1B diabetes care business

May 6, 2021 Auto Bot BioPharma, biopharma nl, diabetes, Medical Devices, New Jersey, Pharma 0

diabetes, insulin

Becton Dickinson is known worldwide for its diabetes products. Now the medical technologies giant plans to spin off its diabetes care business as a separate, publicly traded company, leaving BD to focus on its other core segments.